NCT03950024

Brief Summary

Arthrogenic Muscle Inhibition (AMI) is one of the classic complications occurring in the aftermath of knee trauma; AMI is grossly defined as a lack of extension due to quadriceps inhibition and hamstring contracture. However, its origins remains unknown with a strong suspicion for a central brain origin. It could be the missing link explaining this lack of extension following an anterior cruciate ligament (ACL) rupture. The primary hypothesis of this study is that a difference in activation of motor brain areas exists in patients with an ACL rupture, between those with AMI or without. The second hypothesis is that this difference could be seen on brain functional MRI.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
42

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 9, 2019

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 14, 2019

Completed
6 months until next milestone

Study Start

First participant enrolled

October 29, 2019

Completed
4.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 11, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 11, 2024

Completed
Last Updated

August 27, 2024

Status Verified

August 1, 2024

Enrollment Period

4.6 years

First QC Date

May 9, 2019

Last Update Submit

August 26, 2024

Conditions

Keywords

arthrogenic muscle inhibitionanterior cruciate ligamentfunctional brain MRICentral nervous systemKnee trauma

Outcome Measures

Primary Outcomes (1)

  • Matrix of correlation coefficients

    A matrix of correlation coefficients, measured by MRI, representing the strength of the sensory-motor network connectivity at rest for each group.

    Day 0

Secondary Outcomes (1)

  • Activation map of the motor representations of knee movement

    Day 0

Study Arms (2)

with arthrogenic Muscle Inhibition

EXPERIMENTAL
Diagnostic Test: functional brain MRI

without arthrogenic Muscle Inhibition

ACTIVE COMPARATOR
Diagnostic Test: functional brain MRI

Interventions

functional brain MRIDIAGNOSTIC_TEST

The functional brain MRI realized will be a examination with a resting sequence and a sequence during a movement imagination task. (knee bent)

with arthrogenic Muscle Inhibitionwithout arthrogenic Muscle Inhibition

Eligibility Criteria

Age20 Years - 30 Years
Sexmale(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • male patient, right-handed,
  • with a severe right knee sprain in the event of ACL rupture,
  • with a score of ≥ 8/10 on the Edinburgh Manual Laterality Questionnaire, -affiliated or benefiting from public health services.

You may not qualify if:

  • person presenting any of these conditions : professional player / athlete, -contraindication to the MRI examination (claustrophobic patient, patient with a metallic element),
  • patient already operated on with ligament damage to the knee other than ACL,
  • patient with iterative ACL rupture,
  • patient who has undergone contralateral ligament reconstruction,
  • patient with multi-ligamentary knee injury,
  • patient refusing to be informed of any abnormality detected on brain MRI, -protected patient (adults under guardianship or other legal protection, deprived of their liberty by judicial or administrative decision).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pierre Paul Riquet Hospital

Toulouse, Occitanie, 31300, France

Location

MeSH Terms

Conditions

Anterior Cruciate Ligament Injuries

Condition Hierarchy (Ancestors)

Knee InjuriesLeg InjuriesWounds and Injuries

Study Officials

  • Etienne CAVAIGNAC, MD

    University Hospital, Toulouse

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Model Details: prospective, monocentric, interventional, comparative, controlled, non-randomized study
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 9, 2019

First Posted

May 14, 2019

Study Start

October 29, 2019

Primary Completion

June 11, 2024

Study Completion

June 11, 2024

Last Updated

August 27, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

Locations